EFFECTS OF CYP2D6 AND CYP3A5 GENOTYPES ON THE PLASMA CONCENTRATIONS OF RISPERIDONE AND 9-HYDROXYRISPERIDONE IN KOREAN SCHIZOPHRENIC PATIENTS.

被引：0
|
作者：
Kang, R. [1 ]
Jung, S. [2 ]
Kim, K. [3 ]
Lee, D. [2 ]
Cho, H. [2 ]
Jung, B. [2 ]
Lee, M. [1 ]
Park, J. [3 ]
机构：
[1] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea
[2] Yangsan Neuropsychiat Hosp, Dept Psychiat, Yangsan, South Korea
[3] Korea Univ, Coll Med, Dept Clin Pharmacol & Toxicol, Seoul 136705, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [1] Effects of CYP2D6 and CYP3A5 Genotypes on the Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Korean Schizophrenic Patients
    Kang, Rhee-Hun
    Jung, Sun-Min
    Kim, Kyoung-Ah
    Lee, Duk Ki
    Cho, Hyun-Kee
    Jung, Bong-Joo
    Kim, Young-Ku
    Kim, Seung-Hyun
    Han, Changsu
    Lee, Min-Soo
    Park, Ji-Young
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (03) : 272 - 277
  • [2] Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia
    Yasui-Furukori, N
    Mihara, K
    Kondo, T
    Kubota, T
    Iga, T
    Takarada, Y
    De Vries, R
    Kaneko, S
    Tateishi, T
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (02): : 122 - 127
  • [3] Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia
    Mihara, K
    Kondo, T
    Yasui-Furukori, N
    Suzuki, A
    Ishida, M
    Ono, S
    Kubota, T
    Iga, T
    Takarada, Y
    de Vries, R
    Kaneko, S
    THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 287 - 293
  • [4] QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations
    Llerena, A
    Berecz, R
    Dorado, P
    de la Rubia, A
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (02) : 189 - 193
  • [5] Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography:: application to the evaluation of CYP2D6 drug interactions
    Llerena, A
    Berecz, R
    Dorado, P
    de la Garza, CS
    Norberto, MJ
    Cáceres, M
    Gutiérrez, JR
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 783 (01): : 213 - 219
  • [6] Population Pharmacokinetic Modeling of Risperidone and 9-Hydroxyrisperidone to Estimate CYP2D6 Subpopulations in Children and Adolescents
    Sherwin, Catherine M. T.
    Saldana, Shannon N.
    Bies, Robert R.
    Aman, Michael G.
    Vinks, Alexander A.
    THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 535 - 544
  • [7] Impact of CYP2D6 Genotype on Steady-State Serum Concentrations of Risperidone and 9-Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone
    Hendset, Magnhild
    Molden, Espen
    Refsum, Helge
    Hermann, Monica
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (06) : 537 - 541
  • [8] Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1
    Yoo, Hee-Doo
    Cho, Hea-Young
    Lee, Sang-No
    Yoon, Hwa
    Lee, Yong-Bok
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (04) : 329 - 341
  • [9] Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1
    Hee-Doo Yoo
    Hea-Young Cho
    Sang-No Lee
    Hwa Yoon
    Yong-Bok Lee
    Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 329 - 341
  • [10] Prolactin levels: sex differences in the effects of risperidone, 9-hydroxyrisperidone levels, CYP2D6 and ABCB1 variants
    Schoretsanitis, Georgios
    de Leon, Jose
    Diaz, Francisco J.
    PHARMACOGENOMICS, 2018, 19 (10) : 815 - 823
12345